CANYON CAPITAL ADVISORS LLC 13D and 13G filings for Acorda Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:52 pm Sale |
2022-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
CANYON CAPITAL ADVISORS LLC | 0 0.000% |
-32,452 (Position Closed) |
Filing |
| 2022-02-14 4:56 pm Purchase |
2021-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
CANYON CAPITAL ADVISORS LLC | 32,452 5.790% |
22,633 (+230.52%) |
Filing |
| 2021-04-28 6:13 pm Sale |
2020-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
CANYON CAPITAL ADVISORS LLC | 9,818 1.820% |
-65,179 (-86.91%) |
Filing |
| 2021-02-16 4:16 pm Purchase |
2020-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
CANYON CAPITAL ADVISORS LLC | 74,997 13.910% |
74,997 (New Position) |
Filing |